Success Metrics

Clinical Success Rate
100.0%

Based on 6 completed trials

Completion Rate
100%(6/6)
Active Trials
1(14%)
Results Posted
83%(5 trials)

Phase Distribution

Ph phase_3
7
100%

Phase Distribution

0

Early Stage

0

Mid Stage

7

Late Stage

Phase Distribution7 total trials
Phase 3Large-scale testing
7(100.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

6 of 6 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

7

all time

Status Distribution
Active(1)
Completed(6)

Detailed Status

Completed6
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
1
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 37 (100.0%)

Trials by Status

active_not_recruiting114%
completed686%

Recent Activity

1 active trials
Showing 5 of 7
active_not_recruitingphase_3

Long-term Safety and Efficacy Extension Trial of Bimatoprost SR

NCT03891446
completedphase_3

Evaluation of the Duration of Effect of Bimatoprost SR in Participants With Open-Angle Glaucoma or Ocular Hypertension

NCT03850782
completedphase_3

Comparison of Bimatoprost Sustained Release (SR) to Selective Laser Trabeculoplasty (SLT) in Adults With Open-Angle Glaucoma or Ocular Hypertension

NCT02507687
completedphase_3

A Phase 3b Study Evaluating the 24-Hour Intraocular Pressure Lowering Effect of Bimatoprost SR in Patients With Open-Angle Glaucoma or Ocular Hypertension

NCT04285580
completedphase_3

A Comparison of Bimatoprost SR to Selective Laser Trabeculoplasty in Patients With Open-Angle Glaucoma or Ocular Hypertension

NCT02636946
View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials
NCT03891446Phase 3

Long-term Safety and Efficacy Extension Trial of Bimatoprost SR

Active Not Recruiting
NCT03850782Phase 3

Evaluation of the Duration of Effect of Bimatoprost SR in Participants With Open-Angle Glaucoma or Ocular Hypertension

Completed
NCT02507687Phase 3

Comparison of Bimatoprost Sustained Release (SR) to Selective Laser Trabeculoplasty (SLT) in Adults With Open-Angle Glaucoma or Ocular Hypertension

Completed
NCT04285580Phase 3

A Phase 3b Study Evaluating the 24-Hour Intraocular Pressure Lowering Effect of Bimatoprost SR in Patients With Open-Angle Glaucoma or Ocular Hypertension

Completed
NCT02636946Phase 3

A Comparison of Bimatoprost SR to Selective Laser Trabeculoplasty in Patients With Open-Angle Glaucoma or Ocular Hypertension

Completed
NCT02250651Phase 3

Efficacy and Safety of Bimatoprost Sustained-Release (SR) in Patients With Open-Angle Glaucoma or Ocular Hypertension

Completed
NCT02247804Phase 3

Efficacy and Safety Study of Bimatoprost Sustained-Release (SR) in Participants With Open-angle Glaucoma or Ocular Hypertension

Completed

All 7 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
7